ResearcherCentro di Riferimento Oncologico della BasilicataActive in the last 2 years

Fabiana Crispo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5712-5021; OpenAlex author ID A5080047785. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

N-Acetyl Aspartic Acid (NAA) Attenuates Stemness and Epithelial-Mesenchymal Transition and Enhances Radio- and Chemo-Sensitivity in Pancreatic Ductal Adenocarc… Co-author DOI 10.3390/cells15171616 ↗
The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications. Co-author DOI 10.3390/biom15020275 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Carmela Mazzoccoli · 2 shared papers, 2025–2026 · strength 0.49
- Paper N-Acetyl Aspartic Acid (NAA) Attenuates Stemness and Epithelial-Mesenchymal Transition and Enhances Radio- and Chemo-Se… DOI 10.3390/cells15171616 ↗
- Paper The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications. DOI 10.3390/biom15020275 ↗
Rosalia Dieli · 2 shared papers, 2025–2026 · strength 0.49
- Paper N-Acetyl Aspartic Acid (NAA) Attenuates Stemness and Epithelial-Mesenchymal Transition and Enhances Radio- and Chemo-Se… DOI 10.3390/cells15171616 ↗
- Paper The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications. DOI 10.3390/biom15020275 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.